SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Illumina, Inc. – ‘10-Q’ for 4/3/22 – ‘EX-101.SCH’

On:  Thursday, 5/5/22, at 4:09pm ET   ·   For:  4/3/22   ·   Accession #:  1110803-22-21   ·   File #:  1-35406

Previous ‘10-Q’:  ‘10-Q’ on 11/5/21 for 10/3/21   ·   Next:  ‘10-Q’ on 8/11/22 for 7/3/22   ·   Latest:  ‘10-Q’ on 5/3/24 for 3/31/24   ·   15 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/05/22  Illumina, Inc.                    10-Q        4/03/22   68:7.4M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.07M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
11: R1          Cover Page                                          HTML     73K 
12: R2          Condensed Consolidated Balance Sheets               HTML    121K 
13: R3          Condensed Consolidated Statements of Income         HTML    116K 
14: R4          Condensed Consolidated Statements of Comprehensive  HTML     41K 
                Income                                                           
15: R5          Condensed Consolidated Statements of Stockholders?  HTML    103K 
                Equity                                                           
16: R6          Condensed Consolidated Statements of Cash Flows     HTML    120K 
17: R7          Organization and Significant Accounting Policies    HTML     45K 
18: R8          Revenue                                             HTML     59K 
19: R9          Investments and Fair Value Measurements             HTML     91K 
20: R10         Debt                                                HTML     58K 
21: R11         Stockholders? Equity                                HTML     74K 
22: R12         Supplemental Balance Sheet Details                  HTML     58K 
23: R13         Legal Proceedings                                   HTML     34K 
24: R14         Income Taxes                                        HTML     26K 
25: R15         Segment Information                                 HTML     55K 
26: R16         Organization and Significant Accounting Policies    HTML     44K 
                (Policies)                                                       
27: R17         Organization and Significant Accounting Policies    HTML     30K 
                (Tables)                                                         
28: R18         Revenue (Tables)                                    HTML     53K 
29: R19         Investments and Fair Value Measurements (Tables)    HTML     85K 
30: R20         Debt (Tables)                                       HTML     42K 
31: R21         Stockholders? Equity (Tables)                       HTML     96K 
32: R22         Supplemental Balance Sheet Details (Tables)         HTML     69K 
33: R23         Segment Information (Tables)                        HTML     50K 
34: R24         Organization and Significant Accounting Policies -  HTML     44K 
                Narrative - Accounting Pronouncements Adopted in                 
                2022 (Details)                                                   
35: R25         Organization and Significant Accounting Policies -  HTML     30K 
                Summary of Calculation of Weighted Average Shares                
                used to Calculate Basic and Diluted Earnings Per                 
                Share (Details)                                                  
36: R26         Revenue - Disaggregation of Revenue (Details)       HTML     55K 
37: R27         Revenue - Remaining Performance Obligation          HTML     38K 
                (Details)                                                        
38: R28         Revenue - Narrative (Details)                       HTML     30K 
39: R29         Investments and Fair Value Measurements -           HTML     97K 
                Narrative (Details)                                              
40: R30         Investments and Fair Value Measurements -           HTML     26K 
                Marketable Equity Securities (Details)                           
41: R31         Investments and Fair Value Measurements - Fair      HTML     60K 
                Value Hierarchy of Assets and Liabilities                        
                (Details)                                                        
42: R32         Investments and Fair Value Measurements - Changes   HTML     36K 
                in Estimated Fair Value of Acquisition Related                   
                Contingent Consideration Liabilities (Details)                   
43: R33         Debt - Summary of Term Debt Obligations (Details)   HTML     44K 
44: R34         Debt - Narrative (Details)                          HTML    136K 
45: R35         Debt - Summary of Convertible Debt Obligations      HTML     40K 
                (Details)                                                        
46: R36         Stockholders? Equity - Narrative (Details)          HTML     24K 
47: R37         Stockholders? Equity - Summary of Restricted Stock  HTML     51K 
                Activity and Related Information (Details)                       
48: R38         Stockholders? Equity - Summary of Stock Option      HTML     43K 
                Activity Under all Stock Option Plans (Details)                  
49: R39         Stockholders? Equity - Narrative - Liability -      HTML     33K 
                Classified Award (Details)                                       
50: R40         Stockholders? Equity - Liability - Classified       HTML     31K 
                Awards (Details)                                                 
51: R41         Stockholders? Equity - Narrative - Employee Stock   HTML     29K 
                Purchase Plan (Details)                                          
52: R42         Stockholders? Equity - Narrative - Share            HTML     28K 
                Repurchases (Details)                                            
53: R43         Stockholders? Equity - Summary of Share-based       HTML     51K 
                Compensation Expense for all Stock Awards                        
                (Details)                                                        
54: R44         Stockholders? Equity- Summary of Assumptions Used   HTML     47K 
                to Estimate the Weighted Average Fair Value Per                  
                Share (Details)                                                  
55: R45         Supplemental Balance Sheet Details - Schedule of    HTML     28K 
                Accounts Receivable (Details)                                    
56: R46         Supplemental Balance Sheet Details - Summary of     HTML     33K 
                Inventory (Details)                                              
57: R47         Supplemental Balance Sheet Details - Summary of     HTML     36K 
                Accrued Liabilities (Details)                                    
58: R48         Supplemental Balance Sheet Details - Summary of     HTML     28K 
                Changes in Reserve for Product Warranties                        
                (Details)                                                        
59: R49         Supplemental Balance Sheet Details - Narrative -    HTML     28K 
                Warranties (Details)                                             
60: R50         Supplemental Balance Sheet Details - Narrative -    HTML     29K 
                Derivatives (Details)                                            
61: R51         Legal Proceedings (Details)                         HTML     33K 
62: R52         Income Taxes (Details)                              HTML     26K 
63: R53         Segment Information - Summary of Operating          HTML     51K 
                Performance and Assets by Segment (Details)                      
66: XML         IDEA XML File -- Filing Summary                      XML    120K 
64: XML         XBRL Instance -- ilmn-20220403_htm                   XML   1.62M 
65: EXCEL       IDEA Workbook of Financial Reports                  XLSX     79K 
 7: EX-101.CAL  XBRL Calculations -- ilmn-20220403_cal               XML    167K 
 8: EX-101.DEF  XBRL Definitions -- ilmn-20220403_def                XML    612K 
 9: EX-101.LAB  XBRL Labels -- ilmn-20220403_lab                     XML   1.44M 
10: EX-101.PRE  XBRL Presentations -- ilmn-20220403_pre              XML    876K 
 6: EX-101.SCH  XBRL Schema -- ilmn-20220403                         XSD    135K 
67: JSON        XBRL Instance as JSON Data -- MetaLinks              381±   544K 
68: ZIP         XBRL Zipped Folder -- 0001110803-22-000021-xbrl      Zip    267K

‘EX-101.SCH’   —   XBRL Schema — ilmn-20220403

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with Wdesk from Workiva -->
<!-- Copyright 2022 Workiva -->
<!-- r:0a65fb8c-ef7f-4fce-a8f6-e1bf71e7b247,g:1b67248c-d8e7-4ef7-b488-dd7d774aace8 -->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ilmn="http://www.illumina.com/20220403" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.illumina.com/20220403">
<xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
<xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
<xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
<xs:annotation>
<xs:appinfo>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ilmn-20220403_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ilmn-20220403_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ilmn-20220403_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ilmn-20220403_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:roleType id="CoverPage" roleURI="http://www.illumina.com/role/CoverPage">
<link:definition> 0001001 - Document - Cover Page </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.illumina.com/role/CondensedConsolidatedBalanceSheets">
<link:definition> 1001002 - Statement - Condensed Consolidated Balance Sheets </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedStatementsofIncome" roleURI="http://www.illumina.com/role/CondensedConsolidatedStatementsofIncome">
<link:definition> 1002003 - Statement - Condensed Consolidated Statements of Income </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.illumina.com/role/CondensedConsolidatedStatementsofComprehensiveIncome">
<link:definition> 1003004 - Statement - Condensed Consolidated Statements of Comprehensive Income </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://www.illumina.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
<link:definition> 1004005 - Statement - Condensed Consolidated Statements of Stockholders’ Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.illumina.com/role/CondensedConsolidatedStatementsofCashFlows">
<link:definition> 1005006 - Statement - Condensed Consolidated Statements of Cash Flows </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSignificantAccountingPolicies" roleURI="http://www.illumina.com/role/OrganizationandSignificantAccountingPolicies">
<link:definition> 2101101 - Disclosure - Organization and Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSignificantAccountingPoliciesPolicies" roleURI="http://www.illumina.com/role/OrganizationandSignificantAccountingPoliciesPolicies">
<link:definition> 2202201 - Disclosure - Organization and Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSignificantAccountingPoliciesTables" roleURI="http://www.illumina.com/role/OrganizationandSignificantAccountingPoliciesTables">
<link:definition> 2303301 - Disclosure - Organization and Significant Accounting Policies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSignificantAccountingPoliciesNarrativeAccountingPronouncementsAdoptedin2022Details" roleURI="http://www.illumina.com/role/OrganizationandSignificantAccountingPoliciesNarrativeAccountingPronouncementsAdoptedin2022Details">
<link:definition> 2404401 - Disclosure - Organization and Significant Accounting Policies - Narrative - Accounting Pronouncements Adopted in 2022 (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="OrganizationandSignificantAccountingPoliciesSummaryofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsPerShareDetails" roleURI="http://www.illumina.com/role/OrganizationandSignificantAccountingPoliciesSummaryofCalculationofWeightedAverageSharesusedtoCalculateBasicandDilutedEarningsPerShareDetails">
<link:definition> 2405402 - Disclosure - Organization and Significant Accounting Policies - Summary of Calculation of Weighted Average Shares used to Calculate Basic and Diluted Earnings Per Share (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Revenue" roleURI="http://www.illumina.com/role/Revenue">
<link:definition> 2106102 - Disclosure - Revenue </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueTables" roleURI="http://www.illumina.com/role/RevenueTables">
<link:definition> 2307302 - Disclosure - Revenue (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueDisaggregationofRevenueDetails" roleURI="http://www.illumina.com/role/RevenueDisaggregationofRevenueDetails">
<link:definition> 2408403 - Disclosure - Revenue - Disaggregation of Revenue (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueRemainingPerformanceObligationDetails" roleURI="http://www.illumina.com/role/RevenueRemainingPerformanceObligationDetails">
<link:definition> 2409404 - Disclosure - Revenue - Remaining Performance Obligation (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueRemainingPerformanceObligationDetails_1" roleURI="http://www.illumina.com/role/RevenueRemainingPerformanceObligationDetails_1">
<link:definition> 2409404 - Disclosure - Revenue - Remaining Performance Obligation (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RevenueNarrativeDetails" roleURI="http://www.illumina.com/role/RevenueNarrativeDetails">
<link:definition> 2410405 - Disclosure - Revenue - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InvestmentsandFairValueMeasurements" roleURI="http://www.illumina.com/role/InvestmentsandFairValueMeasurements">
<link:definition> 2111103 - Disclosure - Investments and Fair Value Measurements </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InvestmentsandFairValueMeasurementsTables" roleURI="http://www.illumina.com/role/InvestmentsandFairValueMeasurementsTables">
<link:definition> 2312303 - Disclosure - Investments and Fair Value Measurements (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InvestmentsandFairValueMeasurementsNarrativeDetails" roleURI="http://www.illumina.com/role/InvestmentsandFairValueMeasurementsNarrativeDetails">
<link:definition> 2413406 - Disclosure - Investments and Fair Value Measurements - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InvestmentsandFairValueMeasurementsMarketableEquitySecuritiesDetails" roleURI="http://www.illumina.com/role/InvestmentsandFairValueMeasurementsMarketableEquitySecuritiesDetails">
<link:definition> 2414407 - Disclosure - Investments and Fair Value Measurements - Marketable Equity Securities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InvestmentsandFairValueMeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails" roleURI="http://www.illumina.com/role/InvestmentsandFairValueMeasurementsFairValueHierarchyofAssetsandLiabilitiesDetails">
<link:definition> 2415408 - Disclosure - Investments and Fair Value Measurements - Fair Value Hierarchy of Assets and Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InvestmentsandFairValueMeasurementsChangesinEstimatedFairValueofAcquisitionRelatedContingentConsiderationLiabilitiesDetails" roleURI="http://www.illumina.com/role/InvestmentsandFairValueMeasurementsChangesinEstimatedFairValueofAcquisitionRelatedContingentConsiderationLiabilitiesDetails">
<link:definition> 2416409 - Disclosure - Investments and Fair Value Measurements - Changes in Estimated Fair Value of Acquisition Related Contingent Consideration Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Debt" roleURI="http://www.illumina.com/role/Debt">
<link:definition> 2117104 - Disclosure - Debt </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DebtTables" roleURI="http://www.illumina.com/role/DebtTables">
<link:definition> 2318304 - Disclosure - Debt (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DebtSummaryofTermDebtObligationsDetails" roleURI="http://www.illumina.com/role/DebtSummaryofTermDebtObligationsDetails">
<link:definition> 2419410 - Disclosure - Debt - Summary of Term Debt Obligations (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DebtNarrativeDetails" roleURI="http://www.illumina.com/role/DebtNarrativeDetails">
<link:definition> 2420411 - Disclosure - Debt - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DebtSummaryofConvertibleDebtObligationsDetails" roleURI="http://www.illumina.com/role/DebtSummaryofConvertibleDebtObligationsDetails">
<link:definition> 2421412 - Disclosure - Debt - Summary of Convertible Debt Obligations (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquity" roleURI="http://www.illumina.com/role/StockholdersEquity">
<link:definition> 2122105 - Disclosure - Stockholders’ Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquityTables" roleURI="http://www.illumina.com/role/StockholdersEquityTables">
<link:definition> 2323305 - Disclosure - Stockholders’ Equity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.illumina.com/role/StockholdersEquityNarrativeDetails">
<link:definition> 2424413 - Disclosure - Stockholders’ Equity - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquitySummaryofRestrictedStockActivityandRelatedInformationDetails" roleURI="http://www.illumina.com/role/StockholdersEquitySummaryofRestrictedStockActivityandRelatedInformationDetails">
<link:definition> 2425414 - Disclosure - Stockholders’ Equity - Summary of Restricted Stock Activity and Related Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquitySummaryofStockOptionActivityUnderallStockOptionPlansDetails" roleURI="http://www.illumina.com/role/StockholdersEquitySummaryofStockOptionActivityUnderallStockOptionPlansDetails">
<link:definition> 2426415 - Disclosure - Stockholders’ Equity - Summary of Stock Option Activity Under all Stock Option Plans (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquityNarrativeLiabilityClassifiedAwardDetails" roleURI="http://www.illumina.com/role/StockholdersEquityNarrativeLiabilityClassifiedAwardDetails">
<link:definition> 2427416 - Disclosure - Stockholders’ Equity - Narrative - Liability - Classified Award (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquityLiabilityClassifiedAwardsDetails" roleURI="http://www.illumina.com/role/StockholdersEquityLiabilityClassifiedAwardsDetails">
<link:definition> 2428417 - Disclosure - Stockholders’ Equity - Liability - Classified Awards (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquityNarrativeEmployeeStockPurchasePlanDetails" roleURI="http://www.illumina.com/role/StockholdersEquityNarrativeEmployeeStockPurchasePlanDetails">
<link:definition> 2429418 - Disclosure - Stockholders’ Equity - Narrative - Employee Stock Purchase Plan (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquityNarrativeShareRepurchasesDetails" roleURI="http://www.illumina.com/role/StockholdersEquityNarrativeShareRepurchasesDetails">
<link:definition> 2430419 - Disclosure - Stockholders’ Equity - Narrative - Share Repurchases (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquitySummaryofSharebasedCompensationExpenseforallStockAwardsDetails" roleURI="http://www.illumina.com/role/StockholdersEquitySummaryofSharebasedCompensationExpenseforallStockAwardsDetails">
<link:definition> 2431420 - Disclosure - Stockholders’ Equity - Summary of Share-based Compensation Expense for all Stock Awards (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="StockholdersEquitySummaryofAssumptionsUsedtoEstimatetheWeightedAverageFairValuePerShareDetails" roleURI="http://www.illumina.com/role/StockholdersEquitySummaryofAssumptionsUsedtoEstimatetheWeightedAverageFairValuePerShareDetails">
<link:definition> 2432421 - Disclosure - Stockholders’ Equity- Summary of Assumptions Used to Estimate the Weighted Average Fair Value Per Share (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalBalanceSheetDetails" roleURI="http://www.illumina.com/role/SupplementalBalanceSheetDetails">
<link:definition> 2133106 - Disclosure - Supplemental Balance Sheet Details </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalBalanceSheetDetailsTables" roleURI="http://www.illumina.com/role/SupplementalBalanceSheetDetailsTables">
<link:definition> 2334306 - Disclosure - Supplemental Balance Sheet Details (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalBalanceSheetDetailsScheduleofAccountsReceivableDetails" roleURI="http://www.illumina.com/role/SupplementalBalanceSheetDetailsScheduleofAccountsReceivableDetails">
<link:definition> 2435422 - Disclosure - Supplemental Balance Sheet Details - Schedule of Accounts Receivable (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalBalanceSheetDetailsSummaryofInventoryDetails" roleURI="http://www.illumina.com/role/SupplementalBalanceSheetDetailsSummaryofInventoryDetails">
<link:definition> 2436423 - Disclosure - Supplemental Balance Sheet Details - Summary of Inventory (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalBalanceSheetDetailsSummaryofAccruedLiabilitiesDetails" roleURI="http://www.illumina.com/role/SupplementalBalanceSheetDetailsSummaryofAccruedLiabilitiesDetails">
<link:definition> 2437424 - Disclosure - Supplemental Balance Sheet Details - Summary of Accrued Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalBalanceSheetDetailsSummaryofChangesinReserveforProductWarrantiesDetails" roleURI="http://www.illumina.com/role/SupplementalBalanceSheetDetailsSummaryofChangesinReserveforProductWarrantiesDetails">
<link:definition> 2438425 - Disclosure - Supplemental Balance Sheet Details - Summary of Changes in Reserve for Product Warranties (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalBalanceSheetDetailsNarrativeWarrantiesDetails" roleURI="http://www.illumina.com/role/SupplementalBalanceSheetDetailsNarrativeWarrantiesDetails">
<link:definition> 2439426 - Disclosure - Supplemental Balance Sheet Details - Narrative - Warranties (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalBalanceSheetDetailsNarrativeDerivativesDetails" roleURI="http://www.illumina.com/role/SupplementalBalanceSheetDetailsNarrativeDerivativesDetails">
<link:definition> 2440427 - Disclosure - Supplemental Balance Sheet Details - Narrative - Derivatives (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LegalProceedings" roleURI="http://www.illumina.com/role/LegalProceedings">
<link:definition> 2141107 - Disclosure - Legal Proceedings </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LegalProceedingsDetails" roleURI="http://www.illumina.com/role/LegalProceedingsDetails">
<link:definition> 2442428 - Disclosure - Legal Proceedings (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxes" roleURI="http://www.illumina.com/role/IncomeTaxes">
<link:definition> 2143108 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesDetails" roleURI="http://www.illumina.com/role/IncomeTaxesDetails">
<link:definition> 2444429 - Disclosure - Income Taxes (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentInformation" roleURI="http://www.illumina.com/role/SegmentInformation">
<link:definition> 2145109 - Disclosure - Segment Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentInformationTables" roleURI="http://www.illumina.com/role/SegmentInformationTables">
<link:definition> 2346307 - Disclosure - Segment Information (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SegmentInformationSummaryofOperatingPerformanceandAssetsbySegmentDetails" roleURI="http://www.illumina.com/role/SegmentInformationSummaryofOperatingPerformanceandAssetsbySegmentDetails">
<link:definition> 2447430 - Disclosure - Segment Information - Summary of Operating Performance and Assets by Segment (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xs:appinfo>
</xs:annotation>
<xs:element id="ilmn_SequencingMember" abstract="true" name="SequencingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_DebtInstrumentRenewalTerm" abstract="false" name="DebtInstrumentRenewalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="ilmn_GRAILInc.Member" abstract="true" name="GRAILInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_BusinessAcquisitionEquityOrDebtFinancingThreshold" abstract="false" name="BusinessAcquisitionEquityOrDebtFinancingThreshold" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_BusinessAcquisitionContingentValueRightsRevenueThreshold" abstract="false" name="BusinessAcquisitionContingentValueRightsRevenueThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsForfeitedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_CoreIlluminaMember" abstract="true" name="CoreIlluminaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_ContingentPaymentRightsAxis" abstract="true" name="ContingentPaymentRightsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
<xs:element id="ilmn_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomeAndUSForeignTaxCreditsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxesIncomeAndUSForeignTaxCreditsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_PaymentRightsOfAboveOneBillionEachTwelveYearsMember" abstract="true" name="PaymentRightsOfAboveOneBillionEachTwelveYearsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_BusinessAcquisitionContingentValueRightsTerm" abstract="false" name="BusinessAcquisitionContingentValueRightsTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="ilmn_LiabilityBasedAwardsMember" abstract="true" name="LiabilityBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsGrantedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_TermNotesDue2031Member" abstract="true" name="TermNotesDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_IncreaseDecreaseOfOperatingLeasesNet" abstract="false" name="IncreaseDecreaseOfOperatingLeasesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_ConvertibleSeniorNotesDue2021Member" abstract="true" name="ConvertibleSeniorNotesDue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_ConvertibleSeniorNotesDue2023Member" abstract="true" name="ConvertibleSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_CoveredRevenuesOfGRAILContingentConsiderationLiability" abstract="false" name="CoveredRevenuesOfGRAILContingentConsiderationLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame" abstract="false" name="RevenueRecognitionMultipleDeliverableArrangementsDeliveryTimeFrame" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="ilmn_BusinessAcquisitionContingentValueRightsProRataOnePercentage" abstract="false" name="BusinessAcquisitionContingentValueRightsProRataOnePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="ilmn_DebtInstrumentConvertibleThresholdNoteTradingDays" abstract="false" name="DebtInstrumentConvertibleThresholdNoteTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="ilmn_DebtInstrumentConvertibleThresholdConsecutiveNoteTradingDays" abstract="false" name="DebtInstrumentConvertibleThresholdConsecutiveNoteTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="ilmn_PaymentsForStrategicInvestments" abstract="false" name="PaymentsForStrategicInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_CostOfServicesMember" abstract="true" name="CostOfServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_StandardProductWarrantyDescriptionTerm" abstract="false" name="StandardProductWarrantyDescriptionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
<xs:element id="ilmn_TermNotesDue2023Member" abstract="true" name="TermNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_SwinglineBorrowingsMember" abstract="true" name="SwinglineBorrowingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_PacificBiosciencesofCaliforniaIncPacBioMember" abstract="true" name="PacificBiosciencesofCaliforniaIncPacBioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_InstrumentsMember" abstract="true" name="InstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_ContingentValueRightFairValueDisclosure" abstract="false" name="ContingentValueRightFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_PerformanceSharesGrantedIn2019Member" abstract="true" name="PerformanceSharesGrantedIn2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_StockIssuedDuringPeriodNetOfRepurchasesValue" abstract="false" name="StockIssuedDuringPeriodNetOfRepurchasesValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_HelixHoldingsILLCMember" abstract="true" name="HelixHoldingsILLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardAggregateIntrinsicValueNonvested" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_MicroarrayMember" abstract="true" name="MicroarrayMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_BusinessAcquisitionContingentValueRightsProRataTwoPercentage" abstract="false" name="BusinessAcquisitionContingentValueRightsProRataTwoPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="ilmn_StockIssuedDuringPeriodNetOfRepurchasesShares" abstract="false" name="StockIssuedDuringPeriodNetOfRepurchasesShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
<xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
<xs:element id="ilmn_DebtInstrumentConvertibleThresholdPercentageOfNotePriceTrigger" abstract="false" name="DebtInstrumentConvertibleThresholdPercentageOfNotePriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardLiabilityClassifiedAwardsOutstandingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatio" abstract="false" name="DebtInstrumentCovenantMinimumDebtToEBITDARatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
<xs:element id="ilmn_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_NumberOfInvestmentFunds" abstract="false" name="NumberOfInvestmentFunds" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="ilmn_A2000EmployeeStockPurchasePlanMember" abstract="true" name="A2000EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_ProceedsFromStrategicInvestments" abstract="false" name="ProceedsFromStrategicInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_PaymentRightsOfOneBillionEachTwelveYearsMember" abstract="true" name="PaymentRightsOfOneBillionEachTwelveYearsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_BusinessCombinationContingentConsiderationLiabilityMember" abstract="true" name="BusinessCombinationContingentConsiderationLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_VentureCapitalInvestmentFundTheFundMember" abstract="true" name="VentureCapitalInvestmentFundTheFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_PerformanceSharesGrantedIn2020Member" abstract="true" name="PerformanceSharesGrantedIn2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings" abstract="false" name="DebtInstrumentFaceAmountOptionalIncreaseInAdditionalBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_A2015StockAndIncentiveCompensationPlanAnd2005SolexaEquityPlanMember" abstract="true" name="A2015StockAndIncentiveCompensationPlanAnd2005SolexaEquityPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_ContingentPaymentRightsDomain" abstract="true" name="ContingentPaymentRightsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_TheCreditAgreementMember" abstract="true" name="TheCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition" abstract="false" name="DebtInstrumentCovenantMinimumDebtToEBITDARatioUponConsummationOfAcquisition" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
<xs:element id="ilmn_SBNorthstarLPMember" abstract="true" name="SBNorthstarLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_RemainingCapitalCommitment" abstract="false" name="RemainingCapitalCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_DebtInstrumentNumberOfRenewals" abstract="false" name="DebtInstrumentNumberOfRenewals" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="ilmn_AdjustmentsToAdditionalPaidInCapitalExchangeOfContingentConsideration" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalExchangeOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_GRAILIncMember" abstract="true" name="GRAILIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_ContingentValueRightUnrealizedGainLoss" abstract="false" name="ContingentValueRightUnrealizedGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_ShareBasedPaymentArrangementPerformanceStockOptionMember" abstract="true" name="ShareBasedPaymentArrangementPerformanceStockOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_VentureCapitalInvestmentFundTheFundOneMember" abstract="true" name="VentureCapitalInvestmentFundTheFundOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_AccruedLiabilityClassifiedAwardsCurrent" abstract="false" name="AccruedLiabilityClassifiedAwardsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
<xs:element id="ilmn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfEmployeesAffectedByModification" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfEmployeesAffectedByModification" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
<xs:element id="ilmn_VentureCapitalInvestmentFundTheFundTwoMember" abstract="true" name="VentureCapitalInvestmentFundTheFundTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_TermNotesMember" abstract="true" name="TermNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
<xs:element id="ilmn_LossContingencyRoyaltyOnInvolvedProductsPercentage" abstract="false" name="LossContingencyRoyaltyOnInvolvedProductsPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
<xs:element id="ilmn_ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock" abstract="false" name="ShareBasedPaymentArrangementLiabilityClassifiedAwardsActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
<xs:element id="ilmn_CostOfGoodsSoldMember" abstract="true" name="CostOfGoodsSoldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>

9 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/05/23  Illumina, Inc.                    10-Q        4/02/23   67:7.1M
 2/07/23  Illumina, Inc.                    8-K:2,9     2/07/23   11:1.2M
 1/11/23  Illumina, Inc.                    8-K:2,9     1/09/23   13:332K
12/01/22  Illumina, Inc.                    424B2                  2:533K                                   Donnelley … Solutions/FA
11/29/22  Illumina, Inc.                    424B2                  1:500K                                   Donnelley … Solutions/FA
11/04/22  Illumina, Inc.                    10-Q       10/02/22   70:8.9M
11/03/22  Illumina, Inc.                    8-K:2,9    11/03/22   11:1.1M
 8/11/22  Illumina, Inc.                    10-Q        7/03/22   72:9M
 8/11/22  Illumina, Inc.                    8-K:2,9     8/11/22   11:1M

6 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/18/22  Illumina, Inc.                    10-K        1/02/22  108:15M
 8/18/21  Illumina, Inc.                    8-K:1,2,8,9 8/18/21   12:686K                                   Cravath Swaine & … 01/FA
 4/28/21  Illumina, Inc.                    10-Q        4/04/21   62:6.5M
 1/02/20  Illumina, Inc.                    8-K:1,7,9   1/02/20   14:223K
 9/26/19  Illumina, Inc.                    8-K:1,9     9/25/19   13:218K
11/05/18  Illumina, Inc.                    8-K:1,5,8,910/31/18    4:705K
↑Top
Filing Submission 0001110803-22-000021   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 14, 2:09:09.2pm ET